Expression of bisecting glcNAc in pediatric brain tumors and its association with tumor cell response to vinblastine

Clinical Cancer Research

Volumn 5, Issue 11, 1999, Pages 3661-3668

  Rebbaa, Abdelhadi ^a   Chou, Pauline M ^a   Vucic, Ivica ^a   Mirkin, Bernard L ^a   Tomita, Tadanori ^a   Bremer, Eric G ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; GLYCOPROTEIN P; LECTIN; TUMOR MARKER; VINBLASTINE;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER CELL CULTURE; CANCER GRADING; CHILDHOOD CANCER; CONTROLLED STUDY; EPENDYMOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; TUMOR GROWTH;

ACETYLGLUCOSAMINE; ASTROCYTOMA; BRAIN NEOPLASMS; CARBOHYDRATE SEQUENCE; CELL DIVISION; CEREBELLAR NEOPLASMS; CEREBRAL CORTEX; EPENDYMOMA; GLIOMA; GLYCOSYLATION; HUMANS; LECTINS; MEDULLOBLASTOMA; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; P-GLYCOPROTEIN; PHYTOHEMAGGLUTININS; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0032753478     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Mizoguchi, A., Takazaki, S., Maeda, S., and Kobata, A. Changes in asparagine-linked sugar chains of human promyelocytic leukemia cells (HL60) during monocytic differentiation and myeloid differentiation. Appearance of high mannose-type oligosaccharides in neutral fraction. J. Biol. Chem., 2.59: 11943-11948, 1984.
2. Kroczak, B., Goss, P., Fernandez, B., Baker, M., and and Dennis, J. W. Branching N-linked oligosaccharides in breast cancer. Adv. Exp. Med. Biol., 353: 95-104, 1994.
3. Hffernan, M., Lotan, R., Amos, B., Palcic, M., Takano, R., and Dennis, J. W. Branching β1-6N-acetylglucosamine transferases and polylactosamine expression in mouse F9 teratocarcinoma cells and differentiated couterparts. J. Biol. Chem., 268: 1242-1251, 1993.
4. Saito, H., Nishikawa, A., Gu, J., Ihara, Y., Soejima, H., Wada, Y., Sekiya, C., and Taniguchi, N. cDNA cloning and chromosomal mapping of human N-acetylglucosaminyltransferase V. Biochem. Biophys. Res. Commun., 198: 318-327, 1994.
5. Yamashita, K., Hitoi, K., and Kobata, A. Structural determinants of Phaseolus vulgaris erythroagglutinating lectin for oligosaccharides. J. Biol. Chem., 258: 14753-14755, 1987.
6. Taniguchi, N., and Ihara, Y. Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases. Glycoconj. J., 12: 733-738, 1995.
7. Mori, S., Aoyagi, Y., Suzuki, Y. M., and Asakura, H. Serum N-acetylglucosaminyltransferase III activities in hepatocellular carcinoma. J. Gastroenterol. Hepatol., 13: 610-619, 1998.
8. Ross, S. A., Jones, C. S., and De Luca, L. M. Retinoic acid and methotrexate specifically increase PHA-E lectin binding to a 67 kDa glycoprotein in LAN-1 human neuroblastoma cells. Int. J. Cancer, 62: 303-308, 1995.
9. Rebbaa, A., Yamamoto, H., Saito, S., Meuillet, E., Kim, P., Kersey, D. S., Bremer, E. G., Taniguchi, N., and Moskal, J. R. Gene transfection-mediated overexpression of β1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function. J. Biol. Chem., 272: 9275-9279, 1997.
10. Ihara, Y., Sakamoto, Y., Mihara, M., Shimizu, K., and Taniguchi, N. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor. J. Biol. Chem., 272: 9629-9634, 1997.
11. Yoshimura, M., Ihara, Y., and Taniguchi, N. Changes of β1,4-N-acetylglucosaminyltransferase III (GnT-III) in patients with leukaemia. Glycoconj. J., 12: 234-240, 1995.
12. Ueda, K., Clark, D. P., Chen, C. J., Roninson, I. B., Gottesman, M. M., and Pastan, I. The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation. J. Biol. Chem., 262: 505-508, 1987.
13. Roninson, I. B. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. New York: Plenum Press, 1991.
14. Lehnert, M. Chemotherapy resistance in breast cancer. Anticancer Res., 18: 2225-2226, 1998.
15. Horio, M., Gottesman, M. M., and Pastan, I. ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells. Proc. Natl. Acad. Sci. USA, 85: 3580-3584, 1988.
16. Scinkel, A. H., Kemp, S., Dolle, M., Rudenko, G., and Wagenaar, E. N-glycosylation and deletion mutants of the human MDR1 P-glyco-protein. J. Biol. Chem., 268: 7474-7481, 1993.
17. Kleihues, P., Burger, P. C., and Scheithauer, B. W. The new WHO classification of brain tumors. Brain Pathol., 3. 255-268, 1993.
18. Kolchinsky, A., and Roninson, I. B. Drug resistance conferred by mdr1 expression in spheroids formed by glioblastoma cell lines. Anti-cancer Res., 17: 3321-3328, 1997.
19. Fernandes, B., Sagman, U., Auger, M., Demetrio, M., and Dennis, J. W. β1-6 branched oligosaccharides as marker of tumor progression in human breast and colon neoplasia. Cancer Res., 51: 718-723, 1991.
20. Zambenedetti, P., Giordano, R., and Zatta, P. Identification of lectin binding sites in the rat brain. Glycoconj. J., 13: 341-346, 1996.
21. Kondo, S., Yin, D., Morimura, T., Oda, Y., Kikuchi, H., and Takeuchi, J. Transfection with bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression. Cancer Res., 54: 2928-2933, 1994.
22. Chen, G., Duran, G. E., Steger, K. A., Lacayo, N. J., Jaffrezou, J. P., Dumontet, C., and Sikic, B. I. Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins. J. Biol. Chem., 272: 5974-5982, 1997.
23. Abe, T., Mon, T., Wakabayashi, Y., Nakagawa, M., Cole, P. S., Koike, K., Kuwano, M., and Hori, S. Expression of multidrug resistance protein gene in patients with glioma after chemotherapy. J. Neurooncol.,40: 11-18, 1998.
24. Chou, P. M., Barquin, N., and Gonzalez-Crussi, F. Ependymomas in children express the multidrug resistance gene: immunohostochemical and molecular biologic study. Ped. Pathol. Lab. Med., 16: 551-561. 1996.
25. Rebbaa, A., Yamamoto, H., Moskal, J. R., and Bremer, E. G. Binding of erythroagglutinating phytohemagglutinin lectin from Phaseolus vulgaris to the epidermal growth factor receptor inhibits receptor function in the human glioma cell line, U373 MG. J. Neurochem., 67: 2265-2272, 1996.
26. Dietrich, U., Lucius, J., Baron, E., Behnke, J., Bapst, B., and Zoll, B. Distribution of epidermal growth factor receptor gene amplification in brain tumors and correlation to prognosis. J. Neurol., 242: 683-688, 1995.
27. Van Eldik, L. J., Jensen, R. A., Ehrenfried, B. A., and Whetsell, W. O. Jr. Immunohistochemical localization of S100 β in human nervous system tumors by using monoclonal antibodies with specificity for the S100 β polypeptide. J. Histochem. Cytochem., 34: 977-982, 1986.
28. Inoue, H. K., Kunimine, H., Zamma, A., Ono, N., and Nakamura, M. Clinical pathology of primitive gliomas in the cerebrum. Acta Neurochir. (Wien), 81: 94-99, 1986.
29. Kondziolka, D., and Bilbao, J. M. Mixed ependymoma-astrocytoma (Subependymoma?) of the cerebral cortex. Acta Neuropathol., 76: 633-637, 1988.
30. Cohen, M. E., and Duffner, P. K. Brain Tumors in Children: Principles of Diagnosis and Treatment, p. 219. New York: Raven Press, 1997.